A citation-based method for searching scientific literature

Sa A Wang, Naomi Galili, Jan Cerny, Eric Sechman, Su Sin Chen, Jerome Loew, Qin Liu, Oluwole Fadare, Robert Hasserjian, Dan Jones, Huma Qawi, Bruce Woda, Azra Raza. Am J Clin Pathol 2006
Times Cited: 28







List of co-cited articles
203 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prognostic score including gene mutations in chronic myelomonocytic leukemia.
Raphaël Itzykson, Olivier Kosmider, Aline Renneville, Véronique Gelsi-Boyer, Manja Meggendorfer, Margot Morabito, Céline Berthon, Lionel Adès, Pierre Fenaux, Odile Beyne-Rauzy,[...]. J Clin Oncol 2013
381
35


The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
James W Vardiman, Jüergen Thiele, Daniel A Arber, Richard D Brunning, Michael J Borowitz, Anna Porwit, Nancy Lee Harris, Michelle M Le Beau, Eva Hellström-Lindberg, Ayalew Tefferi,[...]. Blood 2009
25

SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).
Manja Meggendorfer, Andreas Roller, Torsten Haferlach, Christiane Eder, Frank Dicker, Vera Grossmann, Alexander Kohlmann, Tamara Alpermann, Kenichi Yoshida, Seishi Ogawa,[...]. Blood 2012
224
25

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia.
Esperanza Such, Ulrich Germing, Luca Malcovati, José Cervera, Andrea Kuendgen, Matteo G Della Porta, Benet Nomdedeu, Leonor Arenillas, Elisa Luño, Blanca Xicoy,[...]. Blood 2013
202
25


International scoring system for evaluating prognosis in myelodysplastic syndromes.
P Greenberg, C Cox, M M LeBeau, P Fenaux, P Morel, G Sanz, M Sanz, T Vallespi, T Hamblin, D Oscier,[...]. Blood 1997
21

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients.
Francesco Onida, Hagop M Kantarjian, Terry L Smith, Greg Ball, Michael J Keating, Elihu H Estey, Armand B Glassman, Maher Albitar, Monica I Kwari, Miloslav Beran. Blood 2002
280
21

Proposals for the classification of the myelodysplastic syndromes.
J M Bennett, D Catovsky, M T Daniel, G Flandrin, D A Galton, H R Gralnick, C Sultan. Br J Haematol 1982
21

Frequent pathway mutations of splicing machinery in myelodysplasia.
Kenichi Yoshida, Masashi Sanada, Yuichi Shiraishi, Daniel Nowak, Yasunobu Nagata, Ryo Yamamoto, Yusuke Sato, Aiko Sato-Otsubo, Ayana Kon, Masao Nagasaki,[...]. Nature 2011
21

Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease.
Leonardo Boiocchi, Rosanny Espinal-Witter, Julia Turbiner Geyer, Julia Steinhilber, Irina Bonzheim, Daniel M Knowles, Falko Fend, Attilio Orazi. Mod Pathol 2013
53
21

Cytogenetic risk stratification in chronic myelomonocytic leukemia.
Esperanza Such, José Cervera, Dolors Costa, Francesc Solé, Teresa Vallespí, Elisa Luño, Rosa Collado, María J Calasanz, Jesús M Hernández-Rivas, Juan C Cigudosa,[...]. Haematologica 2011
191
21

Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm.
Falko Fend, Thomas Horn, Ina Koch, Teresa Vela, Attilio Orazi. Leuk Res 2008
29
17

Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology.
Attilio Orazi, Ronald Chiu, Dennis P O'Malley, Magdalena Czader, Susan L Allen, Caroline An, Gail H Vance. Mod Pathol 2006
56
17

Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
Véronique Gelsi-Boyer, Virginie Trouplin, José Adélaïde, Julien Bonansea, Nathalie Cervera, Nadine Carbuccia, Arnaud Lagarde, Thomas Prebet, Meyer Nezri, Danielle Sainty,[...]. Br J Haematol 2009
451
17

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.
E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, A Pellagatti, J S Wainscoat, E Hellstrom-Lindberg, C Gambacorti-Passerini,[...]. N Engl J Med 2011
878
17

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.
T Haferlach, Y Nagata, V Grossmann, Y Okuno, U Bacher, G Nagae, S Schnittger, M Sanada, A Kon, T Alpermann,[...]. Leukemia 2014
998
17


The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
17

Mutation in TET2 in myeloid cancers.
François Delhommeau, Sabrina Dupont, Véronique Della Valle, Chloé James, Severine Trannoy, Aline Massé, Olivier Kosmider, Jean-Pierre Le Couedic, Fabienne Robert, Antonio Alberdi,[...]. N Engl J Med 2009
14

JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia.
A Pich, L Riera, F Sismondi, L Godio, L Davico Bonino, F Marmont, P Francia di Celle. J Clin Pathol 2009
33
14

Identification of risk factors in atypical chronic myeloid leukemia.
Massimo Breccia, Francesca Biondo, Roberto Latagliata, Ida Carmosino, Franco Mandelli, Giuliana Alimena. Haematologica 2006
65
14

Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia.
J M Hernández, M C del Cañizo, A Cuneo, J L García, N C Gutiérrez, M González, G Castoldi, J F San Miguel. Ann Oncol 2000
80
14

Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization.
G M Rigolin, A Cuneo, M G Roberti, A Bardi, G Castoldi. Haematologica 1997
28
14

RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
Clara Ricci, Elisa Fermo, Stefania Corti, Mauro Molteni, Alessio Faricciotti, Agostino Cortelezzi, Giorgio Lambertenghi Deliliers, Miloslav Beran, Francesco Onida. Clin Cancer Res 2010
98
14

Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value.
Alexander E Smith, Azim M Mohamedali, Austin Kulasekararaj, ZiYi Lim, Joop Gäken, Nicholas C Lea, Bartlomiej Przychodzen, Syed A Mian, Erick E Nasser, Claire Shooter,[...]. Blood 2010
189
14

Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1.
Alexander Kohlmann, Vera Grossmann, Hans-Ulrich Klein, Sonja Schindela, Tamara Weiss, Beray Kazak, Frank Dicker, Susanne Schnittger, Martin Dugas, Wolfgang Kern,[...]. J Clin Oncol 2010
239
14

Clinical effect of point mutations in myelodysplastic syndromes.
Rafael Bejar, Kristen Stevenson, Omar Abdel-Wahab, Naomi Galili, Björn Nilsson, Guillermo Garcia-Manero, Hagop Kantarjian, Azra Raza, Ross L Levine, Donna Neuberg,[...]. N Engl J Med 2011
14

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.
Anna M Jankowska, Hideki Makishima, Ramon V Tiu, Hadrian Szpurka, Yun Huang, Fabiola Traina, Valeria Visconte, Yuka Sugimoto, Courtney Prince, Christine O'Keefe,[...]. Blood 2011
251
14

Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
Julia E Maxson, Jason Gotlib, Daniel A Pollyea, Angela G Fleischman, Anupriya Agarwal, Christopher A Eide, Daniel Bottomly, Beth Wilmot, Shannon K McWeeney, Cristina E Tognon,[...]. N Engl J Med 2013
361
14

CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
A Pardanani, T L Lasho, R R Laborde, M Elliott, C A Hanson, R A Knudson, R P Ketterling, J E Maxson, J W Tyner, A Tefferi. Leukemia 2013
176
14

Clonal architecture of chronic myelomonocytic leukemias.
Raphaël Itzykson, Olivier Kosmider, Aline Renneville, Margot Morabito, Claude Preudhomme, Céline Berthon, Lionel Adès, Pierre Fenaux, Uwe Platzbecker, Olivier Gagey,[...]. Blood 2013
195
14

Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias.
E Schuler, M Schroeder, J Neukirchen, C Strupp, B Xicoy, A Kündgen, B Hildebrandt, R Haas, N Gattermann, U Germing. Leuk Res 2014
56
14

Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.
Sa A Wang, Robert P Hasserjian, Patricia S Fox, Heesun J Rogers, Julia T Geyer, Devon Chabot-Richards, Elizabeth Weinzierl, Joseph Hatem, Jesse Jaso, Rashmi Kanagal-Shamanna,[...]. Blood 2014
127
14

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies.
E Padron, G Garcia-Manero, M M Patnaik, R Itzykson, T Lasho, A Nazha, R K Rampal, M E Sanchez, E Jabbour, N H Al Ali,[...]. Blood Cancer J 2015
96
14

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients.
M M Patnaik, R Itzykson, T L Lasho, O Kosmider, C M Finke, C A Hanson, R A Knudson, R P Ketterling, A Tefferi, E Solary. Leukemia 2014
198
14

Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.
Julia T Geyer, Wayne Tam, Yen-Chun Liu, Zhengming Chen, Sa A Wang, Carlos Bueso-Ramos, Jean Oak, Daniel A Arber, Eric Hsi, Heesun J Rogers,[...]. Mod Pathol 2017
36
14

Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML.
Dorothée Selimoglu-Buet, Bouchra Badaoui, Emmanuel Benayoun, Andréa Toma, Pierre Fenaux, Bruno Quesnel, Gabriel Etienne, Thorsten Braun, Nassera Abermil, Margot Morabito,[...]. Blood 2017
42
14

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.
Jan Cools, Daniel J DeAngelo, Jason Gotlib, Elizabeth H Stover, Robert D Legare, Jorges Cortes, Jeffrey Kutok, Jennifer Clark, Ilene Galinsky, James D Griffin,[...]. N Engl J Med 2003
10

Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System.
Miloslav Beran, Sijin Wen, Yu Shen, Francesco Onida, Jaroslav Jelinek, Jorge Cortes, Francis Giles, Hagop Kantarjian. Leuk Lymphoma 2007
51
10

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes.
David P Steensma, Gordon W Dewald, Terra L Lasho, Heather L Powell, Rebecca F McClure, Ross L Levine, D Gary Gilliland, Ayalew Tefferi. Blood 2005
347
10

Chronic myelomonocytic leukemia: natural history and prognostic determinants.
A Tefferi, H C Hoagland, T M Therneau, R V Pierre. Mayo Clin Proc 1989
71
10

Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice.
Chaitali Parikh, Ramesh Subrahmanyam, Ruibao Ren. Blood 2006
65
10

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features.
S A Wang, R P Hasserjian, J M Loew, E V Sechman, D Jones, S Hao, Q Liu, W Zhao, M Mehdi, N Galili,[...]. Leukemia 2006
52
10

Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
Yin Xu, Robert W McKenna, Nitin J Karandikar, Alex J Pildain, Steven H Kroft. Am J Clin Pathol 2005
56
10

Chronic myelomonocytic leukemia in the light of the WHO proposals.
Ulrich Germing, Corinna Strupp, Sabine Knipp, Andrea Kuendgen, Aristoteles Giagounidis, Barbara Hildebrandt, Carlo Aul, Rainer Haas, Norbert Gattermann, John M Bennett. Haematologica 2007
49
10


Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.
Francis H Grand, Claire E Hidalgo-Curtis, Thomas Ernst, Katerina Zoi, Christine Zoi, Carolann McGuire, Sebastian Kreil, Amy Jones, Joannah Score, Georgia Metzgeroth,[...]. Blood 2009
300
10

Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
Luca Malcovati, Matteo G Della Porta, Daniela Pietra, Emanuela Boveri, Andrea Pellagatti, Anna Gallì, Erica Travaglino, Angela Brisci, Elisa Rumi, Francesco Passamonti,[...]. Blood 2009
104
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.